Injected carbon nitride particles evoked cortical light responses in blind mice
An Aarhus-led team reports that injectable photocatalytic nanoparticles gave surviving retinal neurons in blind mice a light input, enough for visual cortex activity and a behavioural change, with the cells left genetically untouched.
The Scientist · Science desk
What happened
- Hollow graphitic carbon nitride particles about 300 nanometres across were injected into the eyes of mice with advanced retinitis pigmentosa and settled on the retinal surface near the ganglion cells that signal to the brain.
- When the researchers illuminated those eyes, they recorded light-induced signals in the visual cortex and saw the mice change their behaviour in response.
- In isolated pig retinal tissue, LED light activated ganglion cells whenever the nanoparticles were present, extending the effect beyond mouse tissue.
- The team states plainly that normal vision was not restored in the mice, only a measurable biological response to light in retinas whose photoreceptors had largely degenerated.
Why it matters
- What's now possible capability Injection alone can give surviving ganglion cells a light input, leaving the genes of the cells that fire untouched, so eligibility would not depend on tolerating a viral vector.
- What it limits constraint Detection is settled, localisation is not: in single-cell tests the signal from one activated particle carried into neighbouring cells, and that spread caps how fine a pattern any device built this way could deliver.
- Who's exposed exposure An injected photocatalyst stays in the eye, and the group itself puts chronic tolerability before any human test, work it says it has yet to complete.
Next story · Science · 6d ago
Optogenetic gene therapy is safe in 10 people blinded by retinitis pigmentosa, NEJM trial findsConfirmed2 publishers
Graphitic carbon nitride is a light-driven catalyst, and the particles are hollow spheres around 300 nanometres across whose structure captures visible light efficiently, a design borrowed in part from chloroplasts [9]. What follows in tissue is described only as electrical and chemical processes in the particle's immediate surroundings, close enough to change signalling in nearby cells [10][2]. Safety depends on those specifics. A material doing photochemistry beside a ganglion cell has to be characterised for what it produces and whether it keeps producing it in dim light.
Resolution is harder. In single-cell experiments, a precisely focused laser activated individual particles inside a cell, and the resulting signal travelled through that cell and on to neighbouring cells [11]. How far the signal spreads between neighbours sets how fine a pattern a future prosthesis could deliver, and the mouse readouts leave open how tightly light can be localised on the retina [3].
Ordinary LED light was enough in one of the other preparations. In cardiac muscle cells, LED illumination changed the cells' rhythm and made them beat more synchronously [12]. The move from a focused laser aimed at one particle to broad LED light matters because it decides whether an ordinary light source, and not a microscope, can drive the effect. Only a living eye can show what the particles do over weeks [14].
The approach depends on what retinitis pigmentosa leaves behind: the photoreceptors degenerate, while other retinal cells and their connections can remain intact [8]. "Instead of genetically modifying these cells, we use the nanoparticles to create a new connection between light and the nerve cells," said Menglin Chen, an associate professor at the Department of Biological and Chemical Engineering at Aarhus University [15][7]. Chen said that once the photoreceptors are lost, the options for restoring light sensitivity are still very limited [21].
The project began at Aarhus seven years ago, so around 2019 given the September 2026 date on the phys.org report, with the question of whether a microscopic solar cell could work inside the body [19][18][22]. Chen said the founding problem was whether the team "could create a material that could act as a wireless interface between light and living cells" [6]. The paper is in Nature Biomedical Engineering [5].
The phys.org account leaves out how many animals were tested, what the control conditions were, and the light intensities used [20]. The researchers say long-term safety and function need study in much greater detail before the technology could be tested as a treatment in people [17].
What to watch
- Chronic data in the injected mice: whether the particles stay on the retinal surface, clear, or keep reacting over months.
- A pattern-discrimination task that would put a number on the spatial resolution the particles can support.
- Evidence that light at indoor ambient levels, beyond laboratory LED illumination, can drive ganglion cells in a living eye.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence50
- Adoption2
- Hype gap+10
- Incentives
- Not scored
- Confidence60
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
An international research team developed microscopic particles that act as light receptors and are injected into the eye, where they settle close to nerve cells in the retina.
- [2]
When light hits the particles it triggers electrical and chemical processes that can activate the nerve cells and prompt them to send signals toward the brain.
- [3]
In experiments with blind mice, the researchers detected light-induced signals in the visual cortex and observed behavioural responses to light.
- [4]
The researchers also showed the technology can activate nerve cells in retinal tissue from pigs.
- [5]
The findings were published in Nature Biomedical Engineering.
- [6]
Menglin Chen: "When we started, our fundamental question was whether we could create a material that could act as a wireless interface between light and living cells. We can now see that the particles are able to activate nerve cells in blind retinas. That brings us closer to our long-term goal of developing a new type of retinal prosthesis."
- [7]
Menglin Chen is an associate professor at the Department of Biological and Chemical Engineering at Aarhus University.
- [8]
In retinitis pigmentosa the light-sensitive photoreceptors gradually degenerate, while other nerve cells and connections within the retina can remain intact, and the researchers aim to make use of those surviving cells.
- [9]
The nanoparticles are made from the light-sensitive semiconductor graphitic carbon nitride, measure around 300 nanometres in diameter, are hollow, and have a structure that makes them particularly effective at capturing visible light; the design draws inspiration in part from chloroplasts.
- [10]
When exposed to light the nanoparticles trigger a series of physical and chemical processes in their immediate surroundings, and these processes can influence signalling in living cells.
- [11]
Using a precisely focused laser, the researchers activated individual nanoparticles inside cells and triggered a signal that travelled through the cell and on to neighbouring cells.
- [12]
In cardiac muscle cells, the researchers used ordinary LED light to influence the cells' rhythm and make them beat more synchronously.
- [13]
The researchers injected the nanoparticles into the eyes of mice with advanced retinitis pigmentosa, and the particles accumulated on the surface of the retina, close to the retinal ganglion cells that transmit information from the eye toward the brain.
- [14]
In isolated pig retinal tissue, LED light could activate ganglion cells when the nanoparticles were present.
- [15]
Menglin Chen: "What is particularly interesting is that we are trying to make use of the nerve cells that still function in the retina. Instead of genetically modifying these cells, we use the nanoparticles to create a new connection between light and the nerve cells. In this way, we are trying to make a blind retina respond to light again."
- [16]
The experiments do not mean the researchers restored normal vision in the mice; they show the technology can generate a measurable biological response to light even when the photoreceptors that normally detect light have largely degenerated.
- [17]
The researchers still need to study long-term safety and function in much greater detail before the technology could potentially be tested as a treatment in humans.
- [18]
The phys.org account is dated September 2026.
- [19]
The research project began at Aarhus University seven years ago with the question of whether researchers could develop a kind of microscopic solar cell that could be placed inside the body and use light to control cellular activity.
- [20]
The phys.org account reports no number of animals used, no control conditions, and no light intensity values for the mouse or pig experiments.
- [21]
Chen said that once the photoreceptors are lost, the options for restoring light sensitivity are still very limited, and each approach in development carries its own conditions.
- [22]
A start seven years before a September 2026 report puts the beginning of the Aarhus project at about 2019.
Sources
2 independent publishers whose own reporting we read for this story.
- genengnews.comBiomimetic Nanoparticles Trigger Light Responses in Blind Mouse Retinas
1 article · September 22, 2026
- phys.orgInjectable nanoparticles make blind retinas respond to light in preclinical study
1 article · September 22, 2026
Topics and entities
Topics
- Vision restoration therapy
- Nanomedicine
- Retinitis pigmentosa
Entities
- Nature Biomedical Engineering
- Aarhus University
- Graphitic carbon nitride